Le Lézard
Classified in: Health
Subjects: ASI, DEI

Next-Generation Social Justice Leaders Aspire to Achieve Equitable Health and Well-Being for All


DALLAS, May 28, 2021 /PRNewswire/ -- In appreciation of Asian American and Pacific Islander (AAPI) Heritage Month, the American Heart Association, the leading global voluntary health organization dedicated to fighting heart disease and stroke, is honoring its EmPOWERED to Serve Scholars of Asian American and Pacific Islander decent.  These students are next-generation social justice leaders who are committed to ensuring equitable health and well-being for all.

The EmPOWERED to Serve Scholars initiative awards grants to students who are focused on health impact annually, empowering them to become agents of change in their communities.  The competition is open to first-year college students, sophomores and juniors who are actively addressing social determinants of health, such as food insecurity, safe housing, job opportunities and access to health care. 

"In order to achieve health equity, we know it is essential that the people who are delivering science, research and medicine are diversely represented," said Nancy Brown, chief executive officer of the American Heart Association.  "We are proud to celebrate EmPOWERED to Serve Scholars and applicants from all backgrounds and remain committed to expanding learning experiences and research opportunities for underrepresented racial and ethnic groups."

The following AAPI students were named EmPOWERED to Serve Scholars in 2020:

The American Heart Association featured EmPOWERED to Serve Scholars in the EmPOWERED to Serve Health Justice Roundtable where they addressed racial and health justice. The scholars led the discussion and shared how attendees can be changemakers in their communities. 

The 2021 EmPOWERED Scholars application period will open in late August 2021.To apply, students must submit a resume, letter of recommendation and a personal 60-second video about what health equity means to them and how they have made a sustainable, positive impact on the health of their community or the health of the community where their college/university is located.

For more information, visit the EmPOWERED to Serve Scholars site

Additional Resources

About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public's health, and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1. 

For Media Inquiries:
Natashia Johnson, [email protected], 214.706.1463

For Public Inquiries: 1-800-AHA-USA1 (242-8721)
heart.org and stroke.org

SOURCE American Heart Association


These press releases may also interest you

at 00:25
Zai Lab Limited and Innoviva Specialty Therapeutics today announced that China's National Medical Products Administration (NMPA) has approved Zai Lab's New Drug Application (NDA) for XACDURO® (sulbactam-durlobactam) for the treatment of...

19 mai 2024
Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its...

19 mai 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

19 mai 2024
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

19 mai 2024
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

19 mai 2024
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...



News published on and distributed by: